Banco de Sabadell (BME:SAB) Extends Amundi Deal As Valuation Questions Persist
Banco de Sabadell (BME:SAB) has extended its distribution agreement with Amundi for investment solutions across its Spanish networks to 2035, keeping investor attention on how this long-term tie up could influence the bank’s fund business.
See our latest analysis for Banco de Sabadell.
Banco de Sabadell’s €3.552 share price sits against a 30 day share price return of 10.97% and a one year total shareholder return of 21.82%, with very strong five year total shareholder returns suggesting long term momentum has been in place. Recent gains hint at renewed interest following news such as the extended Amundi partnership.
If this kind of steady banking story has you thinking about what else might be setting up for long term growth, it could be a good time to check out 101 top founder-led companies
After Banco de Sabadell’s recent share price move and the extended Amundi deal, the real question now is whether today’s level already reflects that progress or if patience could offer a more appealing entry.
Most Popular Narrative: 2.6% Overvalued
Banco de Sabadell’s most followed narrative puts fair value at €3.46, slightly below the current €3.552 share price, which keeps valuation questions front and center.
Strong and accelerating loan growth, especially in Spanish mortgages, consumer lending, SME and corporate, public sector, and international portfolios, suggests robust underlying demand for banking services and positions the company for future revenue expansion and higher net interest income. Sustained increase in customer funds, particularly through off balance sheet investment and savings products, demonstrates growing customer engagement and enables greater cross selling of fee based products, supporting long term growth in recurring fee income and revenue diversification.
Investors who follow this narrative may want to understand why it still sees upside even with a tight gap to fair value. The argument leans heavily on compounding revenue, firm margins and a specific earnings path that would need to align very closely with expectations.
Result: Fair Value of €3.46 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this story for Banco de Sabadell still hinges on Spanish focused growth and on margins holding up against regulation, bank taxes and rising cost pressures.
Find out about the key risks to this Banco de Sabadell narrative.
Another View Using the SWS DCF Model
The analyst narrative for Banco de Sabadell points to a fair value of €3.46, which suggests the shares are 2.6% overvalued. Our DCF model presents a different perspective. It points to a fair value of about €4.65, implying the current €3.55 price sits at a sizeable discount. Which set of assumptions do you trust more?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Banco de Sabadell for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 261 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With mixed signals on Banco de Sabadell’s valuation and outlook, it makes sense to look at the detailed data and decide where you stand. To quickly weigh what could go right against what might go wrong, take a close look at the 2 key rewards and 5 important warning signs.
Looking for more ideas beyond Banco de Sabadell?
If you are weighing Banco de Sabadell and want a broader view, it helps to compare it with other stocks that fit clear, focused criteria.
- Spot potential income pillars for your portfolio by checking out 439 dividend fortresses.
- Hunt for quality at a reasonable price through the lens of 261 high quality undervalued stocks.
- Strengthen your downside protection by scanning companies in the 301 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com